PENGARUH TERAPI BEKAM BASAH DALAM MENURUNKAN APOLIPROTEIN-B PADA PENDERITA HIPERKOLESTEROLEMIA

Wahyudi Widada, Teddy Ontoseno, Bambang Purwanto

Abstract


ABSTRACT

Hypercholesterolemia is a high level of cholesterol in the blood. Patients must take anti-cholesterol drugs for a long time, so they are at risk of experiencing side effects from the drug. Apo-B and total cholesterol are indicators of cholesterol levels in the blood. Wet cupping therapy is a method of excreting metabolic waste in the blood through the surface of the skin. The study aims to prove the effect of wet cupping therapy as a complementary therapy to decrease Apolipoprotein-B. Method: This research is Quasy experimental research using humans as research subjects. The dependent variable is Apo-B, and total cholesterol gave wet cupping treatment. Cupping is done twice, 7 points, using a G21 needle. A large sample of 32 people with hypercholesterolemia divided into treatment groups and control groups. The research subjects were selected based on sample inclusion criteria. After 12 hours of fasting and still taking simvastatin, blood was taken through 5ml of the brachial vein. Put into a 2ml purple tube containing EDTA the rest inserted in a red tube. Apo-B measurement using ELISA sandwich method, elabscience reagent, BiopharmaELISA reader tool, in units of ng/ml. Total cholesterol uses the enzymatic colorimetry method, diasys reagent, Biolyzer100 spectrophotometry, in mg/dl units. Data analysis was carried out with the Wilcoxon Signed Ranks Test with a significance level of 5% (α = 0.05), the pre-datacompared with the post data. Results: A significant reduction in Apo-B measurements with p-value 0.000 (α <0.05), SD 42. Conclusion: Intervention of wet cupping therapy can reduce Apo-B levels in the blood. Further research needs to be done to measure the potential for prevention of atherosclerosis.

Keywords: wet cupping, Apo-B, cholesterol, blood

Full Text:

PDF

References


El-Sayed SM, Mahmoud HS and Nabo MMH. 2013. Medical and Scientific Bases of Wet Cupping Therapy; in Light of Modern Medicine and Prophetic Medicine. Alternative and Integrative Medicine 2: 1-16.

Ilkay Chirali, Mark Bovey, Roz Gibbs. 2005. Cupping for Patients with inflammatory Compalints: Clinical and Biochemical Outcomes

Kwiterovich, PO Jr., MD, 2000, The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 2000,86:5L-10L.

Mahdavi, MRV, et al. 2012. Evaluation of the effects of traditional Cupping on the Biochemical, Hematological and Immunological Factors of Human Venous Blood. Viewed 21 Peb 2012

Mourad, SA,and Soad K. Al-Jaouni. 2016. The Effect of Wet Cupping on Blood Haemoglobin Level. Alternative Integration Medition2016, 5:2

Murray Robert K., Granner Daryl K., Rodwell Victor W., 2009. Biokimia Harper, Jakarta: EGC

Mustafa L., Dawood M. Rukzan, Al-Sabaawy M. Osama, 2012. Effect of Wet Cupping on Serum Lipids Profile Level of Hyperlipidemia Patients and Correlation with some Meal Ions. [online] Available at : http://www.iasj.net/iasj?func=fultext&ald=60009.pdf

Niasari M, Kossari F, Ahmadi A, 2007. The Effect of Wet Cuping on Serum Lipid Concentrations of Clinically Healthy. The Journal of Alternative and Complementary Medicine. Volume 13, Number 1, 2007, pp. 79–82

Praningsih, S.2017. Efektifitas Spritual Cupping Care dibandingkan Cupping Care dalam menurunkan Kolesterol LDL. Thesis. Repository Unair

Siadat SO Ranaei., Kheirandish h., Niasari., Adibi Z., Agin K., Tashnizi M B. 2004. The effect of cupping (hejamat) on blood biochemical and immunological parameters. Iranian Journal of Pharmaceutical Research: Supplement 2: 31-32

Subadi, I. 2014. Mekanisme penurunan nyeri inflamasi terapi bekam kering dan bekam basah. Disertasi. Universitas Airlangga. Tidak dipublikasikan

Saryono, 2010. Penurunan kadar kolesterol total pada pasien hipertensi yang mendapat terapi bekam di klinik An-Nahl. Purwokerto. , 5(2), pp.66–73.

Walldius G, and Jungner I. 2004. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine 2004; 255: 188–205.




DOI: https://doi.org/10.32528/psn.v0i0.1730